Friday, 03 Apr 2020

You are here

Kevin Winthrop, MD: H. zoster and tofacitinib: the risk of concomitant nonbiologic therapy

Dr. Kevin Winthrop, associate professor of infectious diseases at Oregon Health & Sciences University in Portland, Oregon, discusses abstract 559.

Add new comment

Want to talk about this video? Comment here to lead the discussion.
MORE VIDEOS

RWCS 2017: Dr. Anne Stevens -...

21 Feb 2017

RheumNow Podcast - The Elusive Hand OA...

13 Dec 2019

Dr. Kevin Winthrop: Zoster Infection...

09 Jan 2017

The RheumNow Week in Review - 27...

27 Oct 2017

The RheumNow Week in Review - 2...

02 Feb 2018

What's Great about the ACR Meeting...

18 Nov 2019

Dr. David Liew: Yellow Fever...

22 Oct 2018

RWCS 2017: Unsuspected Cause of...

19 Apr 2017

Dr. Anna Postolova: MTX in the...

11 Feb 2018

Dr. Olga Petryna: Osteoporotic...

30 Oct 2018

Rituximab as Rescue Therapy in...

17 Feb 2020

Dr. Jack Cush and Dr. Pete Salzmann (...

07 Nov 2017